3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Colorectal Neoplasms
3
Turcot syndrome
2
Medulloblastoma
2
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Rhabdoid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Peutz-Jeghers Syndrome
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Mouth Neoplasms
1
Locally Advanced Rectal Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Ependymoma
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Adenomatous Polyposis Coli
1
Interventions
lutetium Lu 177 dotatate
2
Temozolomide
2
ONC206
2
Etoposide
2
Cyclophosphamide
2
Bevacizumab
2
olaparib
1
neratinib
1
ibrutinib
1
fenofibric acid
1
etoposide phosphate
1
brigatinib
1
Watchful Waiting
1
Thalidomide
1
Restraint, Physical
1
Radiotherapy
1
Radiation
1
Magnetic Resonance Spectroscopy
1
Linear Energy Transfer
1
Irinotecan
1
Elasticity Imaging Techniques
1
Cytarabine
1
Celecoxib
1
Automobiles
1
1-methyltryptophan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ependymoma
×
Celecoxib
×
Clear all
NCT01356290
2026-02-23
MEMMAT
Medical University of Vienna
Phase 2
Recruiting
232 enrolled